Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12613000827730
Ethics application status
Not yet submitted
Date submitted
22/07/2013
Date registered
26/07/2013
Date last updated
26/07/2013
Type of registration
Prospectively registered
Titles & IDs
Public title
Management of dry mouth following radiation therapy: investigation of a new saliva substitute product.
Query!
Scientific title
Management of xerostomia following radiotherapy: a randomised, double blind, cross-over study of a novel emulsion for use as a saliva substitute
Query!
Secondary ID [1]
282848
0
Nil
Query!
Universal Trial Number (UTN)
U1111-1142-6873
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
xerostomia
289656
0
Query!
Condition category
Condition code
Oral and Gastrointestinal
289976
289976
0
0
Query!
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
The intervention is a novel emulsion developed at the University of Otago School of Pharmacy and Sir John Walsh Research Institute which consists of rice bran oil, soy lecithin, propylene glycol and water.
The saliva substitute will be delivered in a metered dose spray bottle. The participant will be asked to use the product at least 4 times per day but more if they wish for one week. They will be asked how often they use the product and how many sprays were required each time. The contents of the return bottle at the end of one week will be measured.
Participants will be asked to use either an active treatment or placebo in a randomised order for one week. There will be a one week wash out period followed by one week use of the alternative product.
Query!
Intervention code [1]
287540
0
Treatment: Other
Query!
Comparator / control treatment
The test product will be compared against 2 products
1) An active control of carboxymethylcellulose saliva substitute, which is currently the only publicly funded saliva substitute available in New Zealand
2) A placebo of water with a flavour added.
Each product will be delivered in a metered dose spray bottle. The participant will be asked to use the product at least 4 times per day but more if they wish for one week. They will be asked how often they use the product and how many sprays were required each time. The contents of the return bottle at the end of one week will be measured.
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
290069
0
Test of Mastication and Swallowing Solids (TOMASS)
Query!
Assessment method [1]
290069
0
Query!
Timepoint [1]
290069
0
The trial tests responses both immediately and after 1 week of use
Query!
Primary outcome [2]
290070
0
Subjective feeling of xerostomia as assessed using the Xerostomia Inventory.
Query!
Assessment method [2]
290070
0
Query!
Timepoint [2]
290070
0
The trial tests responses both immediately and after 1 week of use
Query!
Primary outcome [3]
290071
0
Patient acceptability as measured using a visual analogue scale.
Query!
Assessment method [3]
290071
0
Query!
Timepoint [3]
290071
0
The trials tests responses both immediately and after 1 week of use
Query!
Secondary outcome [1]
303887
0
nil
Query!
Assessment method [1]
303887
0
Query!
Timepoint [1]
303887
0
nil
Query!
Eligibility
Key inclusion criteria
It is a requirement that participants have received radiation therapy to the head and neck region within the last 10 years at Christchurch Hospital.
Participants will be asked a global question regarding xerostomia. "How often does your mouth feel dry?"
Responses are: ‘Never’, ‘Occasionally’, ‘Frequently’, ‘Always’.
Participants who respnd ‘Frequently’ and ‘Always’ will be considered to have xerostomia and will be included in the trial.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Participants who have had surgery as well as radiation therapy for head and neck cancer will not be included. Those who cannot safely swallow solid food will not be included.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Participants will be given the opportunity to participate when they attend routine appointments with their usual oral health care provider (not the primary investigator). They will be provided with information on what the trial involved and have the opportunity to ask questions. They will then sign a consent form.
The participants will be allocated to one of 2 crossover groups by way of random numbers generated by computer. Odd number will be allocated to group one - trial of the new emulsion against a placebo of water
Even number will be allocated to group 2 - trial of carboxymethylcellulose against a placebo of water.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Each participant will then have the order that they receive either the intervention or the placebo randomised by way of random number generation by computer.
A research assistant will put together a randomisation table which will be given to the pharmacist making up the test products. Each bottle will look identical but will be given a unique number on the label according to the randomisation table which ensures the primary investigator does not see which product each participant is using.
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
Query!
Query!
Query!
Query!
Intervention assignment
Crossover
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
A power calculation was carried out using data from a previous study involving participants with Parkinsons disease using TOMASS as an outcome measure. This calculation indicated a sample size of 34 was required, therefore for this trial a sample size of 40 was chosen to allow for drop-out.
For the outcome measures of the xerostomia inventory and the visual analogue scale a multiple linear regression model will be used to assess the difference in each group, adjusting for a difference in sequence of the products.
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
1/09/2013
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
1/09/2014
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
40
Query!
Accrual to date
Query!
Final
Query!
Recruitment outside Australia
Country [1]
5238
0
New Zealand
Query!
State/province [1]
5238
0
Canterbury
Query!
Funding & Sponsors
Funding source category [1]
287668
0
University
Query!
Name [1]
287668
0
University of Otago
Faculty of Dentistry
Query!
Address [1]
287668
0
PO Box 647
Dunedin 9054
Query!
Country [1]
287668
0
New Zealand
Query!
Primary sponsor type
Individual
Query!
Name
Jules Kieser
Query!
Address
Sir John Walsh Research Institute
University of Otago
Faculty of Dentistry
PO Box 647
Dunedin 9054
Query!
Country
New Zealand
Query!
Secondary sponsor category [1]
286404
0
None
Query!
Name [1]
286404
0
nil
Query!
Address [1]
286404
0
Query!
Country [1]
286404
0
Query!
Ethics approval
Ethics application status
Not yet submitted
Query!
Ethics committee name [1]
289632
0
Central Health and Disability Ethics Committee
Query!
Ethics committee address [1]
289632
0
1 The Terrace
PO Box 5013
Wellington 6011
Query!
Ethics committee country [1]
289632
0
New Zealand
Query!
Date submitted for ethics approval [1]
289632
0
25/06/2013
Query!
Approval date [1]
289632
0
Query!
Ethics approval number [1]
289632
0
Query!
Summary
Brief summary
Healthy saliva cleanses and lubricates the mouth, it protects the teeth by reducing bacteria and neutralising acid, and plays a crucial role in tasting, chewing and swallowing of food. A well documented side-effect of radiotherapy for treatment of cancer of the head and neck is a dry mouth due to damage of the surrounding salivary glands (Wijers et al 2002). Such a decrease in saliva flow following radiotherapy results in significant compromise of quality of life and has been shown to lead to an increase in tooth decay and infections in the mouth and cause difficulty with eating and swallowing.
Researchers at the Sir John Walsh Research Institute and the Department of Pharmacy at the University of Otago have recently developed a novel oily formulation for the treatment of dry mouth, to act as a saliva substitute. The aim of this randomised, double blinded, within-subject study is to trial the new formulation as a saliva substitute on measures of mastication, subjective feeling of oral dryness and product acceptibility, and compare outcomes to a currently available saliva substitute and a control of water. Forty participants who have been treated with radiotherapy to the head and neck region will be selected to participate in the trial. Participants will be randomised to receive mouth spray presentations of either an existing saliva substitute or the new formulation; both will use water as a control condition. The researchers and the participants will be blind as to the contents of each spray bottle which will be prepared and labelled in the pharmacy and distributed by a dental assistant.
The differences in each product will be measured using three tests. The first is a simple behavioural test of chewing and swallowing, the second is a questionnaire designed to test the subjective feeling of dry mouth and the third is a questionnairre designed to test the patient acceptibility of each product. Outcome data will be gathered in a single session after the first administration of both the products and placebos to evaluate immediate effects, and after 7 days of use to evaluate longer-term effects. Order of the 7 day use of test product or placebo will be randomised.
The results of this trial will be used in further development of the new saliva substitute, which potentially could influence quality of life and swallowing safety in patients after radiotherapy treatment
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
41506
0
Dr Olivia Apperley
Query!
Address
41506
0
University of Otago
25 Highcrest Heights
Westmorland
Christchurch 8025
Query!
Country
41506
0
New Zealand
Query!
Phone
41506
0
+64211219748
Query!
Fax
41506
0
Query!
Email
41506
0
[email protected]
Query!
Contact person for public queries
Name
41507
0
Dr Olivia Apperley
Query!
Address
41507
0
University of Otago
25 Highcrest Heights
Westmorland
Christchurch 8025
Query!
Country
41507
0
New Zealand
Query!
Phone
41507
0
+64211219748
Query!
Fax
41507
0
Query!
Email
41507
0
[email protected]
Query!
Contact person for scientific queries
Name
41508
0
Dr Olivia Apperley
Query!
Address
41508
0
University of Otago
25 Highcrest Heights
Westmorland
Christchurch 8025
Query!
Country
41508
0
New Zealand
Query!
Phone
41508
0
+64211219748
Query!
Fax
41508
0
Query!
Email
41508
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF